The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
The phrase "patient voice" has become a fixture of clinical development conversations, cited in conference sessions, press releases, and protocol preambles with enough frequency that it risks meaning nothing. What the evidence actually shows is more specific, more uncomfortable, and more actionable than the buzzword suggests.
